Atlas Trials

Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder

Clinical trial NCT01912391 · COMPLETED

Trial details

NCT number
NCT01912391
Sponsor
Mood and Anxiety Research, Inc
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Borderline Personality Disorder
Start date
2012-10-01
Primary completion
2015-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.